Ipamorelin
STUB — Ipamorelin has not been written up yet. Machine-resolvable fields below are populated from PubChem and PubMed; every judgement (mechanism, claims, evidence appraisal) is still missing.
Sequence
No sequence has been verified against a primary source.
How good is the evidence
STUB — evidence has not been appraised. The counts below reflect only what PubMed labelled outright in the sampled records and are a floor, not a total.
The studies themselves
| Study | Design | Subjects | Quality |
|---|---|---|---|
Ipamorelin, the first selective growth hormone secretagogue
Raun K, Andersen PH · European journal of endocrinology · 1998
PMID 9849822
|
unknown / unknown | Mechanistic
risk of bias: unclear
| |
Therapeutic Peptides in Orthopaedics: Applications, Challenges, and Future Directions
Rahman OF, Seeds WA · Journal of the American Academy of Orthopaedic Surgeons. Global research & reviews · 2026
PMID 41490200
|
narrative_review / mixed | Mechanistic
risk of bias: unclear
| |
Injectable Peptide Therapy: A Primer for Orthopaedic and Sports Medicine Physicians
Mayfield CK, Weber AE · The American journal of sports medicine · 2026
PMID 41476424
|
narrative_review / mixed | Mechanistic
risk of bias: unclear
| |
Safety and Efficacy of Approved and Unapproved Peptide Therapies for Musculoskeletal Injuries and Athletic Performance
Mendias CL, Awan TM · Sports medicine (Auckland, N.Z.) · 2026
PMID 41966639
|
narrative_review / mixed | Mechanistic
risk of bias: unclear
|
What we do not know
- This entry is a stub: no claim, mechanism, or evidence appraisal has been written.
- No dose from any cited study is recorded, because no full text has been read.
- The amino-acid sequence has not been verified against a primary source.